KinDex Pharmaceuticals
Seattle
About KinDex Pharmaceuticals
KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders. It was established to focus on the discovery and development of molecules that improve women’s health and impact chronic disease. KinDex Pharmaceuticals is developing therapeutics that work through the Bitter Taste Receptors (TAS2Rs), a family of GPCR receptors that target inflammation and metabolic dysfunction.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $5.8M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Aug 2016)
- Website: kindexpharmaceuticals.com
- Phone: 206-922-2912
Industries & Categories
Biotechnology, Genetics, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/kindex-pharmaceuticals-186997 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.